138 related articles for article (PubMed ID: 9069682)
41. Coming into focus. Pharmacologic treatment for ADHD.
McDonnell MA; Moffett C
Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
[No Abstract] [Full Text] [Related]
42. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
[TBL] [Abstract][Full Text] [Related]
43. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
44. [Central stimulants in adults with AD/HD. Can they be abused?].
Lie N
Tidsskr Nor Laegeforen; 1998 Nov; 118(27):4227-9. PubMed ID: 9857807
[TBL] [Abstract][Full Text] [Related]
45. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
46. Medication for attention deficit hyperactivity disorder: commentary and response.
Faigel HC; Heiligenstein E
J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265
[No Abstract] [Full Text] [Related]
47. Adverse drug reaction. Pemoline and dyskinesia.
Shuster J
Nursing; 1999 Feb; 29(2):24. PubMed ID: 10085879
[No Abstract] [Full Text] [Related]
48. Pemoline therapy resulting in liver transplantation.
Adcock KG; MacElroy DE; Wolford ET; Farrington EA
Ann Pharmacother; 1998 Apr; 32(4):422-5. PubMed ID: 9562136
[TBL] [Abstract][Full Text] [Related]
49. Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults.
Ahmed R; Aslani P
Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):791-815. PubMed ID: 24219052
[TBL] [Abstract][Full Text] [Related]
50. Cognitive performance enhancement: misuse or self-treatment?
Peterkin AL; Crone CC; Sheridan MJ; Wise TN
J Atten Disord; 2011 May; 15(4):263-8. PubMed ID: 20410324
[TBL] [Abstract][Full Text] [Related]
51. Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder.
Bloomingdale LM
J Clin Psychopharmacol; 1990 Oct; 10(5):382-3. PubMed ID: 2124222
[No Abstract] [Full Text] [Related]
52. Pemoline hepatotoxicity in children.
Marotta PJ; Roberts EA
J Pediatr; 1998 May; 132(5):894-7. PubMed ID: 9602211
[TBL] [Abstract][Full Text] [Related]
53. Four cases of severe hepatotoxicity associated with pemoline: possible autoimmune pathogenesis.
Rosh JR; Dellert SF; Narkewicz M; Birnbaum A; Whitington G
Pediatrics; 1998 May; 101(5):921-3. PubMed ID: 9565425
[No Abstract] [Full Text] [Related]
54. Exacerbation of autoimmune hepatitis: another hepatotoxic effect of pemoline therapy.
Hochman JA; Woodard SA; Cohen MB
Pediatrics; 1998 Jan; 101(1 Pt 1):106-8. PubMed ID: 9417161
[No Abstract] [Full Text] [Related]
55. Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.
Shaw P; Sharp WS; Morrison M; Eckstrand K; Greenstein DK; Clasen LS; Evans AC; Rapoport JL
Am J Psychiatry; 2009 Jan; 166(1):58-63. PubMed ID: 18794206
[TBL] [Abstract][Full Text] [Related]
56. Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity.
Collier CP; Soldin SJ; Swanson JM; MacLeod SM; Weinberg F; Rochefort JG
Clin Pharmacokinet; 1985; 10(3):269-78. PubMed ID: 4017397
[TBL] [Abstract][Full Text] [Related]
57. A surveillance method for the early identification of idiosyncratic adverse drug reactions.
Etwel FA; Rieder MJ; Bend JR; Koren G
Drug Saf; 2008; 31(2):169-80. PubMed ID: 18217792
[TBL] [Abstract][Full Text] [Related]
58. Abnormal auditory P300 topography in attention deficit disorder predicts poor response to pemoline.
Sangal JM; Sangal RB; Persky B
Clin Electroencephalogr; 1995 Oct; 26(4):204-13. PubMed ID: 8575100
[TBL] [Abstract][Full Text] [Related]
59. Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment.
Wender PH; Reimherr FW; Wood DR
Arch Gen Psychiatry; 1981 Apr; 38(4):449-56. PubMed ID: 7011250
[TBL] [Abstract][Full Text] [Related]
60. Attention deficit hyperactivity in adults.
Cubbin S; Leahy A
Br J Psychiatry; 1998 Apr; 172():366. PubMed ID: 9715347
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
